medicaid glp 1 weight loss McKee's proposed FY2027 budget drops GLP-1 drugs for from • Rhode Island Current California Medi-Cal halts GLP-1 obesity

The researchers found that compared with topiramate, GLP-1 RA initiators had a lower risk for emergency department visits (risk ratio [RR], 0.90), hospitalizations (RR, 0.86), nerve blocks (RR, 0.87), and triptan use (RR, 0.87)

If approved, semaglutide 7.2 mg would bring patients and healthcare professionals a new option for greater weight loss potential, further underlining the efficacy that the semaglutide molecule can bring

No fees

Consumption of products should be controlled by a professional, if in doubt, always consult your doctor.

The medication that is deemed the best fit will vary from patient to patient and will be decided upon by the patient and their weight loss specialist to choose the option that will yield the most effective, safest, and sustainable results